menu
    • menu

    Company profile for Biofrontera

    NEW Drugs in Dev: 5
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Biofrontera Inc. is a pharmaceutical company, specializing in high quality dermatological products for the care and treatment of skin diseases. Biofrontera’s primary focus is on the development and commercialization of novel therapies for non-melanoma skin cancer. The entire team at Biofrontera consists of highly motivated and exceptionally committed people, aiming to provide high quality products and great service for docto...
    Biofrontera Inc. is a pharmaceutical company, specializing in high quality dermatological products for the care and treatment of skin diseases. Biofrontera’s primary focus is on the development and commercialization of novel therapies for non-melanoma skin cancer. The entire team at Biofrontera consists of highly motivated and exceptionally committed people, aiming to provide high quality products and great service for doctors and their patients. Biofrontera headquarters are located in Leverkusen, Germany, and Biofrontera Inc. has its offices near Boston, MA.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    BiofronteraUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    201 Edgewater Dr Ste 210 Wakefield, MA 01880
    Telephone
    Telephone
    1-844-426-3589
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.biofrontera-us.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/biofrontera-pharma-gmbh
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/hashtag/biofrontera

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    IPhEB Russia

    Not Confirmed

    envelop Contact Supplier

    IPhEB Russia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Biofrontera Reports Record 2025 Financial Results & Business
    Biofrontera Reports Record 2025 Financial Results & Business

    19 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/19/3259125/0/en/Biofrontera-Inc-Reports-Record-Fourth-Quarter-and-Full-Year-2025-Financial-Results-and-Provides-a-Business-Update.html

    GLOBENEWSWIRE
    19 Mar 2026
    Share Share
    Biofrontera Reports Positive Phase 2B Results For Ameluz
    Biofrontera Reports Positive Phase 2B Results For Ameluz

    09 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/09/3251919/0/en/Biofrontera-Inc-Reports-Positive-Phase-2b-Results-Supporting-Further-Development-of-Ameluz-Photodynamic-Therapy-for-moderate-to-severe-Acne-Vulgaris.html

    GLOBENEWSWIRE
    09 Mar 2026
    Share Share
    Biofrontera to Report Q4, Full-Year 2025 Results
    Biofrontera to Report Q4, Full-Year 2025 Results

    09 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/09/3252359/0/en/Biofrontera-Inc-to-Report-Fourth-Quarter-and-Full-Year-2025-Financial-Results-and-Host-a-Conference-Call-on-March-19-2026.html

    GLOBENEWSWIRE
    09 Mar 2026
    Share Share
    U.S. Patent Office Invalidates Sun Pharma Patent 11,697,028
    U.S. Patent Office Invalidates Sun Pharma Patent 11,697,028

    26 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/26/3245710/0/en/U-S-Patent-Office-Issues-Final-Written-Decision-Finding-All-Challenged-Claims-of-Sun-Pharma-s-Patent-11-697-028-To-Be-Unpatentable.html

    GLOBENEWSWIRE
    26 Feb 2026
    Share Share
    Biofrontera Locks Ph1 PK Study of Ameluz for AK
    Biofrontera Locks Ph1 PK Study of Ameluz for AK

    17 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/17/3239403/0/en/Biofrontera-Inc-Announces-Database-Lock-of-Phase-1-Pharmacokinetics-Study-of-Ameluz-for-Actinic-Keratoses-on-Trunk-and-Extremities.html

    GLOBENEWSWIRE
    17 Feb 2026
    Share Share
    Biofrontera Files Supplemental NDA For Ameluz PDT in Carcinoma
    Biofrontera Files Supplemental NDA For Ameluz PDT in Carcinoma

    11 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/11/3236372/0/en/Biofrontera-Announces-FDA-Filing-Acceptance-of-Supplemental-New-Drug-Application-for-Ameluz-PDT-in-Superficial-Basal-Cell-Carcinoma.html

    GLOBENEWSWIRE
    11 Feb 2026
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search